Alpha Cognition Common Stock Net 2020-2024 | ACOG
Alpha Cognition common stock net from 2020 to 2024. Common stock net can be defined as the value of common equity ownership.
Alpha Cognition Annual Common Stock Net
(Millions of US $) |
| 2023 |
$50 |
| 2022 |
$40 |
| 2021 |
$40 |
| 2020 |
$15 |
| 2019 |
$14 |
Alpha Cognition Quarterly Common Stock Net
(Millions of US $) |
| 2024-06-30 |
$49 |
| 2024-03-31 |
$59 |
| 2023-12-31 |
$40 |
| 2023-09-30 |
$43 |
| 2023-06-30 |
$46 |
| 2023-03-31 |
$45 |
| 2022-12-31 |
$40 |
| 2022-09-30 |
$40 |
| 2022-06-30 |
$40 |
| 2022-03-31 |
$40 |
| 2021-12-31 |
$40 |
| 2021-09-30 |
$25 |
| 2021-06-30 |
$25 |
| 2021-03-31 |
$25 |
| 2020-12-31 |
$15 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$14 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
